company background image
S1R logo

Shanghai Pharmaceuticals Holding DB:S1R Stock Report

Last Price

€1.33

Market Cap

€7.3b

7D

-1.5%

1Y

-23.1%

Updated

26 Mar, 2024

Data

Company Financials +

Shanghai Pharmaceuticals Holding Co., Ltd

DB:S1R Stock Report

Market Cap: €7.3b

S1R Stock Overview

Shanghai Pharmaceuticals Holding Co., Ltd.

S1R fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Shanghai Pharmaceuticals Holding Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Pharmaceuticals Holding
Historical stock prices
Current Share PriceCN¥1.33
52 Week HighCN¥1.90
52 Week LowCN¥1.20
Beta0.25
1 Month Change-10.14%
3 Month Change7.26%
1 Year Change-23.12%
3 Year Change-20.36%
5 Year Change-31.79%
Change since IPO-24.00%

Recent News & Updates

Recent updates

Shareholder Returns

S1RDE HealthcareDE Market
7D-1.5%-3.2%1.9%
1Y-23.1%-1.8%7.3%

Return vs Industry: S1R underperformed the German Healthcare industry which returned -2.3% over the past year.

Return vs Market: S1R underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is S1R's price volatile compared to industry and market?
S1R volatility
S1R Average Weekly Movement5.0%
Healthcare Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: S1R has not had significant price volatility in the past 3 months.

Volatility Over Time: S1R's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199447,811Bo Shenhttps://www.sphchina.com

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system.

Shanghai Pharmaceuticals Holding Co., Ltd Fundamentals Summary

How do Shanghai Pharmaceuticals Holding's earnings and revenue compare to its market cap?
S1R fundamental statistics
Market cap€7.30b
Earnings (TTM)€588.43m
Revenue (TTM)€32.60b

13.7x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
S1R income statement (TTM)
RevenueCN¥254.88b
Cost of RevenueCN¥223.22b
Gross ProfitCN¥31.66b
Other ExpensesCN¥27.06b
EarningsCN¥4.60b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)1.24
Gross Margin12.42%
Net Profit Margin1.80%
Debt/Equity Ratio64.5%

How did S1R perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

50%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.